Introduction
Unrestrained growth of cancer cells results in part from an increase in the activity of proliferative signals and loss of signals inhibiting proliferation. The paramount importance of these pathways in oncogenesis is indicated by the high frequency of aberrations in many components of the cell cycle machinery observed in human tumors (Hunter and Pines, 1994) . The cell cycle is governed by the activity of cyclin-dependent kinases (Cdks), which are activated by binding of cyclins and inhibited by binding of Cdk inhibitors. These inhibitors, which include the INK4 family (p15
Ink4b
, p16
Ink4a

, p18
Ink4c and p19
Ink4d
), and the Cip/ Kip family (p21
Cip1
, p27
Kip1 and p57
Kip2
) bind to and inhibit the activity of cyclin-Cdk complexes, thereby blocking cell cycle progression (Kamb, 1995) . The cell cycle inhibitory properties of the Cdk inhibitors make them candidate tumor suppressor genes and in the case of p16 Ink4a (Kamb, 1995) and p27 Kip1 (Fero et al., 1998) this has been demonstrated. Here, we focus on two members of the Cip/Kip family, p27
Kip1 and p21
Cip1
. These proteins share signi®cant sequence homology. A 60 amino acid segment at the amino terminus of human p27 is 44% identical to the equivalent region of human p21 (Toyoshima and Hunter, 1994 ) and this region is required for Cdk inhibitory activity (Nakanishi et al., 1995) . Exogenous expression of p21 and p27 inhibits G1 cyclin/Cdk activity leading to cell cycle arrest (Polyak et al., 1994; Toyoshima and Hunter, 1994; Xiong et al., 1993; Harper et al., 1993; El-Deiry et al., 1994) . Despite these similarities, these proteins are dierentially regulated and have distinct functions.
p27 levels or activity respond to cell-cell contact, treatment with TGFb, mitogens, cAMP and rapamycin, implying that p27 may be a critical component controlling the cell cycle in response to extracellular signals (Sherr and Roberts, 1995) . In general, p27 protein accumulates in quiescent cells and falls in response to mitogenic stimulation; these levels are controlled at both the transcriptional and posttranslational level (Sherr and Roberts, 1995) . Adult p27 knockout mice are *25% larger than normal littermates due to excessive post natal growth which con®rms a function for p27 in growth control in vivo (Fero et al., 1996) . These mice also spontaneously develop pituitary adenomas, but not other tumor types. We have recently shown that both p27 nullizygous (7/7) and heterozygous (+/7) mice are predisposed to the development of adenomas and adenocarcinomas of the lung, small intestine and colon, as well as ovarian and uterine tumors after g-irradiation or treatment with the carcinogen N-ethyl-N-nitrosourea (ENU) (Fero et al., 1998) . Tumors from the heterozygous mice did not mutate or silence expression from the remaining wild-type p27 allele. These studies establish p27 as a haploinsucient tumor suppressor gene for multiple tissues. In humans, homozygous inactivating mutations of p27 in tumors are very infrequent (Pietenpol et al., 1995; PonceCastaneda et al., 1995) . However, p27 protein levels are frequently decreased in a subset of cancers of the breast, colon, esophagus, stomach, lung, and prostate (Tsihlias et al., 1998; Esposito et al., 1997; Singh et al., 1998; Catzavelos et al., 1997; Porter et al., 1997; Mori et al., 1997; Loda et al., 1997) . Patients with low p27 levels in biopsies show signi®cantly worse survival, indicating that p27 protein is an important prognostic marker. In spite of these results, the precise role p27 plays as a tumor suppressor protein is largely unknown.
p21 has been most closely associated with cellular senescence and dierentiation and is a transcriptional target of the tumor suppressor p53. It was isolated from senescent cells where expression levels were high, paralleling their loss of proliferative capacity (Noda et al., 1994) . In mice, p21 expression correlates with dierentiation of several tissues including muscle and intestine (El-Deiry et al., 1995; Parker et al., 1995) and is induced during dierentiation in several systems (Jiang et al., 1994; Steinman et al., 1994) . The transcription factors MyoD and AP-2, both of which induce terminal dierentiation, also induce p21 expression (Zeng et al., 1997; Halevy et al., 1995) . While these studies point to a role for p21 in dierentiation, the observation that p21 null mice exhibit apparently normal development indicate it is not essential. p21 is also transcriptionally activated by the tumor suppressor protein p53 and is a mediator of the G1 checkpoint in response to DNA damage (Harper et al., 1993; El-Deiry et al., 1993) . Mouse embryonic ®broblasts lacking p21 are partially de®cient in their ability to arrest in G1 following DNA damage, whereas apoptosis of p217/7 thymocytes occurs normally (Deng et al., 1995; Brugarolas et al., 1995) . Mice de®cient for p53 are highly predisposed to the development of spontaneous tumors (Donehower et al., 1992) , whereas p21 null mice are not (Deng et al., 1995) . Also, p53 gene mutations are common and found in a variety of malignancies (Levine, 1997) , but no molecular alterations have been reported for the p21 gene (Shiohara et al., 1994) . Thus, while p21 is involved in certain p53-dependent functions, it is not a general mediator of tumor suppression by p53. Nevertheless, the structure and cellular function of p21 suggests a role in cancer.
The aim of the present study was to determine if p27 and/or p21 de®cient mice were susceptible to chemically induced skin tumor development, and if so, to determine the speci®c stage of tumor development at which these gene products might act. We produced skin tumors by treating mice topically with 7,12 dimethylbenz[a]anthracene (DMBA) followed by repeated treatments with the tumor promoter 12-Otetradecanoylphorbol-13-acetate (TPA). This treatment gives rise to papillomas that are hyperplastic, welldierentiated, benign lesions of the skin each originating from a single initiated cell. After a latency of several months, a small percentage of these lesions progress to squamous cell carcinomas which are of a variety of histological subtypes, ranging from welldierentiated stage I to undierentiated stage IV. This model is capable of revealing at which stage of tumor development a suspect cancer gene might act: initiation, re¯ected in the total number of papillomas; promotion, re¯ected in papilloma growth rate; or progression, re¯ected in the conversion of benign papillomas to malignant carcinomas. For example, studies with transgenic mice expressing mutant H-ras in the epidermis, direct skin application of retrovirus expressing mutant H-ras, and chemical carcinogen application showed that mutation of H-ras is an initiating event in this model (Bailleul et al., 1990; Quintanilla et al., 1986; Brown et al., 1986) . In another example, the application of the two-stage skin carcinogenesis model to p53 knockout mice revealed that lack of p53 led to a sharp increase in papilloma to carcinoma conversion and also increased the degree of malignancy and metastasis of carcinomas (Kemp et al., 1993) . There was no increase in the number or growth rate of papillomas indicating that inactivation of p53 was important for malignant progression but did not enhance initiation or promotion.
Our data show no increase in total tumor numbers, but an increased growth rate of benign skin tumors and slightly accelerated conversion to carcinomas in p27 de®cient mice. Thus, p27 de®ciency did not alter initiation, but caused an increase in clonal expansion of initiated cells during promotion. DMBA/TPA treated p277/7 mice also developed adenomas of the small intestine and colon as had been previously seen in p27 de®cient mice treated with g-irradiation or ENU (Fero et al., 1998) . In contrast, p21 de®ciency resulted in a greater percentage of undierentiated carcinomas, indicating a role for p21 in dierentiation late in tumor progression. Thus, although both proteins are fairly universal Cdk inhibitors they have distinctly dierent roles during the natural history of tumor development.
Results
Papilloma growth rate is increased in p277/7 mice but not papilloma number
The p27 knockout allele was on a C57BL/6J genetic background, a strain which is resistant to skin tumor development. We crossed these mice to the sensitive NIH strain and performed the two stage tumor induction protocol on C57BL/6J x NIH F 2 littermates of this cross (see Material and methods). The mean number of papillomas per mouse did not dier between p27 genotypes (Figure 1a) . However, when the rate of appearance of papillomas of dierent size classes was examined, there was a 1.8-fold increase in the incidence rate of papillomas 42 mm in size from p27 null mice compared to wild-type mice (P=0.02) (Figure 1b) . Furthermore, the incidence rate ratio for papillomas 45 mm in size for p27 null vs wild-type mice was 3.3 (P=0.01) (Figure 1c ). This increase in large size class papillomas over time in p27 de®cient mice indicates that papillomas grew signi®cantly faster in these animals.
We con®rmed the generality of this observation by repeating the experiment on a dierent genetic background. An independent skin tumor experiment was done on littermates from a C57BL/6 p27+/7 x 129 p27+/7 cross. Overall papilloma numbers were less on this background. Results were in agreement with the ®rst experiment showing an increase of the papilloma growth rate in p27 null vs wild-type mice, with an incidence rate ratio of 1.9 for papillomas 42 mm in size (P=0.03) (data not shown). Thus, on two dierent genetic backgrounds p27 de®ciency led to increased papilloma growth rate but no increase in total papilloma number.
The incidence rate of papillomas 42 mm in size from p27 heterozygous mice was intermediate to p27 nullizygous and wild-type mice in both experiments but did not reach statistical signi®cance. In the above experiments, tumor promotion was started in 9-weekold mice, which is after p27 de®cient animals have gone through their phase of excessive growth (Fero et al., 1996) . Thus, the weight ratios between p277/7, p27+/7, and p27+/+ mice remained constant throughout the period of tumor promotion (data not shown). Therefore, dierences in the growth rates of the mice do not account for dierences in papilloma growth rates between the genotypes. Another potential source of bias is that some papillomas can regress which might in¯uence the average tumor size. By following the development of number and sizes of papillomas in every individual mouse, we saw no dierence in frequency of papilloma regression between p277/7 and wild-type mice.
Progression of papillomas to carcinomas was also monitored. For the ®rst study, on a C57BL/6J x NIH F 2 background, carcinomas developed earlier in the p277/7 mice (Figure 1d ), but there was no dierence in the conversion rates from papillomas to carcinomas (3% of all papillomas progressed to carcinomas for all three genotypes). Also, the logrank test revealed no statistically signi®cant dierence in carcinoma incidence between p27 null and wild-type mice (P40.1) nor between p27 heterozygous and wild-type mice (P40.3). Similar papilloma to carcinoma conversion frequencies were observed in the second skin tumor study on C57BL/6J x 129 F 1 genetic background and again, no dierence was observed between p277/7 and wild-type mice (data not shown).
By grading the carcinomas into histological subtypes ranging from well-dierentiated grade I to undifferentiated grade IV (Klein-Szanto, 1989) we observed no signi®cant dierence in the degree of malignancy in carcinomas from p277/7 mice (28% poorly differentiated tumors) as compared to wild-type mice (54% poorly dierentiated tumors). However, p277/7 mice had to be sacri®ced earlier than wild-type mice due to the development of internal tumors (see below). Thus, carcinomas had less time to progress which could explain the appearance of fewer poorly dierentiated tumors in p27 null mice. To summarize, p27 de®ciency did not aect total papilloma number but resulted in increased papilloma growth rate and slightly accelerated conversion to carcinomas.
TPA downregulates p27 expression in suprabasal keratinocytes
Given the purported role of p27 in proliferation, we next assessed the eect of TPA and other commonly used tumor promoters on p27 protein levels in epidermal keratinocytes. The dorsal skins of mice were treated with TPA, okadaic acid, or benzoyl peroxide for dierent lengths of time and paran sections were stained with an antibody to p27. All three reagents are known to have a strong tumor promoting eect in mice and to result in marked hyperplasia 1 ± 2 days after treatment (Winberg et al., 1995) .
In untreated and acetone treated control skin, keratinocytes displaying nuclear staining for p27 were observed throughout the epidermis including the basal layer, but mainly in the suprabasal layers ( Figure 2a ). Cells positive for p27 staining were also observed in the bulb region at the base of the hair follicles. In contrast, Ki67 staining, which is a marker of proliferating cells, was only observed in basal cells of the epidermis ( Figure  2b ). TPA treatment led to a striking decrease of nuclear p27 staining in epidermal cells detectable as early as 4 h after treatment and reaching its lowest levels after 24 h ( Figure 2c ). p27 staining in the hair follicle bulb cells remained unchanged. Okadaic acid and benzoyl peroxide caused similar eects but with a delay (lowest levels after 48 h; data not shown). All three promoters caused hyperproliferation of the epidermis as indicated by Ki67 staining at 24 h ( Figure 2d ). Kip1 and p21 Cip1 in skin tumorigenesis J Philipp et al p27 protein expression during skin carcinogenesis Western blot analysis of nuclear extracts from papillomas indicates that p27 protein levels are increased compared to normal skin ( Figure 3) . As shown by immunohistochemistry of papillomas, p27 was expressed in the nuclei of basal cells, along the basement membrane, and in suprabasal cells and was extinguished as cells further dierentiated (Figure 2e ). p27 was not observed in stromal cells. Due to the hyperplastic nature of papillomas, there was a greater percentage of p27-positive cells, while the degree of staining on a per cell basis appeared similar in intensity between papillomas and normal epidermis (compare Figure 2a and e). Western blot analysis showed that in carcinomas, p27 protein was expressed in both low and high grade tumors although the levels varied considerably (Figure 3) . In over 30 tumors examined, we detected no consistent correlation of p27 levels with tumor grade although higher grade tumors tended to
Figure 2 p27 protein expression in normal skin, skin tumors, and after treatment with tumor promoters. Paran imbedded tissue sections of skin, papillomas and carcinomas were stained with antibodies to p27 (a, c, e, f, g, h) or Ki67 (b, d). Normal skin (a) shows nuclear staining for p27 in occasional basal, but predominantly suprabasal cells of the epidermis. Nuclear staining for p27 was also observed in hair follicle cells predominantly in the bulb region and in occasional stromal cells. Ki67 exclusively stains the proliferating basal cells of the epidermis (b). TPA treatment leads to a pronounced downregulation of p27 protein (c) and hyperproliferation with increased Ki67 immunoreactivity (d). Note persistent p27 staining in hair follicle bulb cells. Nuclear staining for p27 is prominent in basal and suprabasal cells of papillomas (e) and expression decreases as cells dierentiate (to right of the ®gure). Underlying stromal cells, to the left, are p27 negative. p27 is also expressed in nuclei of cells in squamous cell carcinomas but in a more disorganized pattern (f). p27 staining was noticeably decreased or undetectable in the poorly dierentiated spindle cell carcinomas (g, lower right). Skin from a p277/7 mouse stained with p27 antibody as a negative control is shown in h (4006) have lower p27 expression. Immunostaining of tissue sections from carcinomas showed nuclear staining for p27 in cells in a less organized pattern relative to papillomas (Figure 2f ). Poorly dierentiated grade IV carcinomas showed p27 staining only in areas with squamous cell characteristics but were consistently much weaker or negative for p27 in areas showing characteristics of spindle cell carcinoma (Figure 2g ).
To summarize, nuclear p27 protein is observed in dierentiating and post-mitotic suprabasal keratinocytes in normal skin. p27 levels increase throughout skin tumor development, but are noticeably decreased or lost in poorly dierentiated spindle cells. Spindle cell carcinomas tend to be more aggressive and have a higher metastatic potential than lower grade squamous cell carcinomas (Buchmann et al., 1991) . Treatment of spheroid cultures of contact-inhibited epithelial cells with a p27 antisense construct caused a loss of cell-cell contact and allowed the cells to migrate and proliferate (St Croix et al., 1996) . Therefore, loss of p27 protein in high grade carcinomas could possibly increase their metastatic potential. However, we did not detect metastases in H+E stained tissue sections of spleen, lymph nodes, liver, and kidney of carcinoma bearing mice of any genotype.
The majority of tumors from p277/7 mice have initiating mutations in the H-ras gene More than 90% of papillomas and carcinomas induced by DMBA/TPA contain the same point mutation in codon 61 of the H-ras gene, which represents an initiating event in skin cancerogenesis ). Duplication of the mutant H-ras allele is also frequently observed suggesting that the dosage of ras and hence ras activity is critical for tumor growth (Bremner and Balmain, 1990 ). It has recently been shown that ras activity late in the G1 phase of the cell cycle is required for p27 downregulation, and G1 to S progression (Kawada et al., 1997; Takuwa and Takuwa, 1997; Aktas et al., 1997) . This prompted us to ask if H-ras mutations and duplication of mutant ras alleles also occurred in tumors of p277/7 mice, or if the absence of p27 had bypassed the need for an increase in ras activity.
Southern blot analysis showed that 12 out of 14 papillomas and carcinomas from p277/7 mice and 11 out of 11 skin tumors from p27+/7 mice contained the expected codon 61 mutation in H-ras (data not shown). Furthermore, duplication of the mutated ras allele was observed in *30% of the tumors tested independent of their p27 genotype (3/12 in p277/7 mice; 3/11 in p27+/7 mice; 5/10 in p27+/+ mice). Thus, p27 de®ciency does not functionally substitute for mutation or increased dosage of H-ras.
p27 de®cient mice are susceptible to intestinal adenomas
During the course of the ®rst skin tumor study, C57BL/ 6JxNIH F 2 p27 null mice had a signi®cantly higher Figure 3 p27 and p21 protein levels in normal skin, papillomas and carcinomas. Western blot analysis was performed using antibodies to p27 and p21. Nuclear extracts of skin, papillomas, or carcinomas of grade I ± VI from wild-type mice were assayed. A total of seven skin samples, 24 papillomas and 21 carcinomas were examined and representative examples are shown. These tumors are from mice from 25 ± 50 weeks post promotion so are unaected by direct application of TPA. p27 protein levels are low in normal skin, prominent in papillomas, and expressed at more variable levels in grade I ± IV carcinomas. p21 protein is not detectable in normal skin and is prominent in papillomas and carcinomas Figure 4 Increased intestinal tumor incidence and overall death rate of p277/7 mice. The cumulative percentage of sacri®ced mice is plotted against the number of weeks after the ®rst treatment with TPA (a). The types of non-skin tumors observed in mice at sacri®ce is tabulated (b). The intestinal, bladder, and cervical tumors and lymphomas resulted in morbidity and sacri®ce. The remaining tumors did not and were detected from mice sacri®ced due to the appearance of squamous cell carcinomas or at the termination of the experiment. Pituitary adenomas were observed in p27 de®cient mice but were not quanti®ed and did not contribute to cumulative mortality p27 Kip1 and p21 Cip1 in skin tumorigenesis J Philipp et al mortality than heterozygous or wild-type mice (Figure 4 ) which was due to earlier carcinoma appearance and to the development of internal tumors. 46% of the p27 null mice developed intestinal adenomas vs. 0% in heterozygous and wild-type mice. These tumors led to obstruction of the small intestine and colon (Figure 5a and b) and contributed to the morbidity. Other tumors found exclusively in p27 null animals were a transitional cell carcinoma of the bladder and a cervical ®broma. The increase in internal tumors in p27 null mice relative to wild types was highly signi®cant (P50.001). Complete necropsy of all mice revealed smaller tumors of the liver, lung, and the urogenital tract largely independent of the p27 genotype. p27 heterozygous mice had a tendency for increased incidence of internal tumors but this did not reach statistical signi®cance (P40.05). This increase in internal tumors, especially intestinal adenomas, was not observed in C57BL6/J x 129 F 1 p277/7 mice from the second experiment. This indicates a genetic background in¯uence on intestinal tumor suppression by p27. The C57BL/6J x NIH background strain conferred susceptibility while the C57BL/6J x 129 background was resistant, thus the dierence in adenoma susceptibility is presumably due to NIH and 129 strain speci®c modi®ers.
Papilloma numbers, growth rate and conversion to carcinomas in p21 de®cient mice
To compare and contrast to results obtained from p27 and p53 de®cient mice (Kemp et al., 1993) , p21 de®cient mice were treated with the same two stage skin carcinogenesis protocol. The mean number of papillomas per mouse was slightly increased in p21 null mice, but this was not statistically sign®cant (poisson regression, P=0.18) (Figure 6a ). There was no dierence between p21 genotypes in the numbers of papillomas 45 mm over time (data not shown). Thus p21 de®ciency did not lead to increased growth rate.
Carcinoma incidence was slightly increased in p217/7 mice (17 out of 24 mice, 71%) vs wild type littermates (11 out of 24 mice, 41%), but this dierence was not statistically signi®cant (P=0.14, Fisher's exact test) (Figure 6b ). Papilloma to carcinoma conversion frequencies were also not dierent (3% for both p217/7 and p21+/+ mice). In contrast to DMBA/ TPA treated p27 or p53 de®cient mice, p21 null mice were not predisposed to death caused by internal tumors.
Carcinomas from p21 null mice are poorly dierentiated
In a previous study, the majority of skin carcinomas induced in p53 de®cient mice were poorly dierentiated grade III to IV squamous and spindle cell carcinomas, whereas typical wild-type tumors were well dierentiated grade I ± II carcinomas (Kemp et al., 1993 ). In the current study, the majority of carcinomas from p21 wild type mice (7/11, 64%) were also well dierentiated squamous cell carcinomas of grade I or II (Figure 5c ). In contrast, most of the carcinomas from p217/7 mice were classi®ed as grade III or IV (14/17, 82%). This dierence was highly signi®cant (P=0.02, Fisher's exact test). Furthermore, the majority of grade IV carcinomas from p217/7 mice (9/12, 75%) were highly anaplastic spindle cell carcinomas. These showed little evidence of cellular organization, squamous dierentiation, or keratin production and they were highly invasive through the muscle layers (Figure 5d ). The cells were densely packed and spindle shaped and the nuclei were elongated but highly variable in size and shape. These tumors showed focal areas of squamous dierentiation indicating that they were derived from squamous epithelium. Two other skin tumors found in the null mice included a ®brosarcoma and a melanoma. Western blot analysis of nuclear extracts from mouse skin showed undetectable levels of p21 protein ( Figure  3 ). Since genetic deletion of p21 led to an increase in the malignant grade of skin carcinomas we reasoned that p21 must be expressed in the course of skin carcinogenesis. Indeed, p21 protein was upregulated in papillomas as well as in carcinomas (Figure 3) . Although p21 levels in carcinomas were generally lower than in the benign tumors, varying levels were found within carcinoma tumor grades. The lowest p21 protein expression was detected in the most poorly dierentiated carcinomas.
Discussion
The relationship of H-ras to p21 and p27 during initiation and promotion
It is well documented that tumor initiation involves mutation of key cellular genes such as H-ras. As both p21 and p27 are involved in cell cycle progression, it is feasible that de®ciency of these proteins could result in increased frequency of mutation, tumor initiation, and hence total papilloma number. p27 null mice did not display an increase in the total number of papillomas arising from the treatment nor did they develop more carcinomas, suggesting that the mechanism of tumor suppression by p27 is unrelated to tumor initiation by DMBA. By the same criteria, p21 de®ciency had no detectable aect on the numbers of skin tumors, indicating that on this genetic background the absence of p21 did not lead to an elevated rate of tumor initiation.
Tissue culture studies have shown that ras and its downstream eectors interact with both p21 and p27. Signaling from ras and raf-1 kinase can induce cell proliferation or cell cycle arrest depending on conditions (Olson et al., 1998; Sewing et al., 1997; Woods et al., 1997) . At high levels of raf signaling, cell cycle arrest was demonstrated which was attributed to accumulation of p21 and Cdk inhibition. We observed signi®cant levels of p21 protein in papillomas from wild type mice compared with normal skin. As the tumor induction kinetics were fairly similar between wild-type and p21 de®cient mice, these levels of p21 were insucient to completely inhibit tumor growth. Tissue culture studies indicated that p21 induction by active ras required active Rho (Olson et al., 1998) ; it would be interesting to determine if Rho is active in TPA treated skin. Alternatively, p21 induction in treated skin could be ras independent.
It has been shown that ras activity late in the G1 phase of the cell cycle down-regulates p27 expression, accompanied by increased Cdk2 and Cdk4 activity, passage through the restriction point and entry into S phase (Aktas et al., 1997; Kawada et al., 1997; Takuwa and Takuwa, 1997) . This showed that ras activity was required up to the restriction point and that downregulation of p27 may be necessary to activate Cdk2 and hence S phase progression.
If the sole function of active ras were to downregulate p27, then a complete absence of p27 might functionally substitute for activated and/or ampli®ed ras. However, the majority of the tumors in both p21 and p27 de®cient mice had the expected activating mutation of H-ras and tumors from each genotype had duplicated the mutated H-ras allele. Ras mutations were also observed in skin tumors from p53 de®cient mice (Kemp et al., 1993) . Thus, despite evidence for functional interactions between active ras signaling and p21 and p27, our results indicate that the absence of p21 or p27 does not alter the requirement for mutational alterations at the H-ras locus during in vivo tumor induction. Clearly, tumor induction by ras involves multiple pathways.
The increased growth rate of papillomas from p27 null mice suggest that during ras driven tumor growth in wild-type mice, p27 might partially antagonize ras signaling and inhibit growth. Genetic deletion of p27 relieves this inhibitory eect. This implies that tumor suppression by p27 may be contingent upon an oncogenic stimulus. This is consistent with the requirement for carcinogenic treatment to induce tumors in p27 de®cient mice (Fero et al., 1998) .
Tumor promoters and p27
In normal mouse epidermis, p27 was expressed mainly in post-mitotic suprabasal keratinocytes which suggests Figure 6 Rate of appearance of papillomas and carcinomas in p21 de®cient mice. The average number of papillomas 42 mm in size is plotted versus the number of weeks after the ®rst treatment with TPA (a). The cumulative incidence of mice with carcinomas is plotted (b). There is no observed eect due to p21 de®ciency a role for p27 in cell cycle exit or dierentiation. A role for p27 in dierentiation has been shown in several dierent cell types in vitro including keratinocytes (Durand et al., 1997; Hauser et al., 1997; Harvat et al., 1998; Casaccia-Bonne®l et al., 1997; Tikoo et al., 1997; Kranenburg et al., 1995) . The striking downregulation of p27 protein following treatment with TPA which we observed, suggests that reduction of p27 may be causally related to the TPA-induced proliferative eect, reduced dierentiation and tumor promotion. Whether the decrease in p27 is necessary or sucient for tumor promotion requires further investigation.
The role of p21 in tumor progression
The conversion of benign papillomas to squamous cell carcinomas is accompanied by multiple cellular and genetic changes. In about 20 ± 30% of cases this includes the complete loss of p53 function by mutation and loss of heterozygosity Burns et al., 1991) . Accordingly, p53 de®cient mice have a high rate of conversion in the two-stage skin carcinogenesis model. Therefore, we asked if p21, which can regulate G1 arrest in a p53-dependent fashion, also functions as a downstream mediator of p53 in skin tumor progression. Progression from papillomas to carcinomas was not signi®cantly increased in p21 de®cient mice, indicating that p21 is not the sole mediator of p53 function at this stage of tumorigenesis. p53 has other functions such as controlling apoptosis, genetic stability, and differentiation (Levine, 1997) . The p21 results reported here suggest that these other functions are more critical than G1 checkpoint control during malignant skin tumor progression.
The majority of carcinomas from DMBA treated wild type mice in this and previous studies are low grade, well dierentiated squamous cell carcinomas. Thus, the increase in poorly dierentiated spindle cell carcinomas observed in p21 nullizygous mice ( Figure  5d ) indicates a signi®cant biological eect of p21 on dierentiation. Other studies point to a role of p21 in normal keratinocyte dierentiation but have relied primarily on expression patterns of p21 or in vitro dierentiation experiments (Di Cunto et al., 1998; Ponten et al., 1995; Hauser et al., 1997; Harvat et al., 1998) . Infection of p21 null keratinocytes with v-ras Ha containing retrovirus and then grafting these onto nude mice resulted in well dierentiated papillomas with no increase in degree of malignancy compared with wildtype keratinocytes (Weinberg et al., 1997) . Results from an independent study of similar design except that the cells were injected subcutaneously produced dierent results (Missero et al., 1996) . There was a much greater yield of tumors derived from p21 null keratinocytes compared to wild types. These tumors were aggressive carcinomas with areas of pronounced anaplasia and invasiveness into surrounding stroma. Our results, obtained from autochthonous tumors without cellular manipulations, demonstrate a role for p21 in tumor dierentiation, but only after conversion to carcinoma occurred. Thus, the tumor stage can in¯uence whether p21 has an eect and this could explain the discrepancy in the two studies described above.
p27 is a multiple tissue tumor suppressor gene An unexpected ®nding was the increase in internal tumors in DMBA/TPA treated p277/7 mice, mostly intestinal adenomas; this was not observed in untreated p27 de®cient mice (Fero et al., 1996) . The carcinogen DMBA was applied to the skin and could have reached the intestine orally or by transdermal absorption. We have now shown that p27 de®cient mice are predisposed to intestinal tumorigenesis induced by four distinct DNA damaging agents: gradiation, ENU (Fero et al., 1998) , DMBA (this report) and 1,2-dimethyl-hydrazine (unpublished observations). The DNA lesions resulting from these four agents have widely dierent mechanisms of repair and mutation. This suggests that tumor suppression by p27 is not involved in any one speci®c pathway of DNA repair or mutation. However, this does not rule out a more global role for p27 in controlling genetic stability.
An important dierence between the skin and intestinal tumor induction protocols is that in the former a strong tumor promoter is applied, which induces clonal expansion and thus detection of the initiated cells as papillomas. The intestinal tumor induction models do not involve tumor promoter application and so initiated cells may remain undetected. Therefore, this model can not readily distinguish between tumor initiation and promotion. Treated wild-type or p27 null mice could have the same number of initiated cells in the intestine but only in the absence of p27 do they clonally expand to detectable adenomas. This interpretation suggests a more general role for p27 in suppressing post-initiation clonal expansion. Further work will be required to address the validity of this interpretation.
Materials and methods
Mice
Mice de®cient for either the p27 or the p21 gene, were obtained from the laboratories of James Roberts (Fero et al., 1996) and Philip Leder (Deng et al., 1995) , respectively. The p27 knockout allele was backcrossed to C57BL/6J for eight generations and the p21 knockout allele was on a mixed Black Swiss6129 background. To increase their susceptibility to skin tumor development, both strains were mated to the susceptible NIH strain (Harlan Olac, UK), and carcinogenesis studies were done on the F 2 littermates of this cross. For the ®rst p27 skin tumor study 27 p27 null, 22 p27 heterozygous and 20 wild-type mice were used. For the second p27 skin tumor study C57BL/6J p27+/7 mice were crossed to 129 p27+/7 mice and tumor induction was done on F 1 littermates. There were 31 p27 null, 42 p27 heterozygous, and 25 wild-type mice. For the p21 skin tumor study we used 24 p217/7 and 24 wild-type mice, also derived from F 2 crosses to NIH mice. The backs of 8-weekold male and female mice were shaved and treated with a single application of DMBA (Sigma Chemical Co.; 25 mg in 200 ml acetone) followed a week later by twice weekly applications of TPA (Sigma Chemical Co.; 200 ml of 10 74 M solution in acetone) for 15 weeks. The number and size of papillomas on each mouse were recorded at regular intervals. Mice were sacri®ced if moribund or following detection of carcinomas. The tumors were frozen for DNA extraction and/or ®xed in formalin, processed and stained with H&E for histological examination. Kip1 and p21 Cip1 in skin tumorigenesis J Philipp et al PCR Toe DNA for genotyping was obtained by digestion with protease K in InstaGene Matrix solution (Bio-Rad, Hercules, CA, USA). Each mouse was genotyped by PCR using primers speci®c for the wild-type or neo interrupted p21 or p27 locus. p27 primers were as described (Fero et al., 1996) . The p21 primers used were neo5 (5'-CTACCCGCTTC-CATTGCTCA-3') and mgc10 (5'-GACCCAGTCCACACC-CAGTG-3') to amplify a 0.6 kb mutant fragment and mcc8 (5'-CGAAAACGGAGGCAGACCAG-3') and mcc9 (5'-CGTGGGCACTTCAGGGTTTTC-3') to obtain a 0.7 kb wild-type PCR fragment.
Southern
DNA was extracted from tumors and Southern blot analysis for H-ras mutations was performed as described (Kemp et al., 1993) . Intensity of bands was determined by densitometry to measure multiplication of the mutant ras allele.
Western
In order to remove abundant keratin present in papillomas and carcinomas, nuclear extracts were prepared as described (Schreiber et al., 1989) with modi®cations. Pieces of skin, papillomas, or carcinomas were ground in liquid nitrogen with a mortar and pestle and the resulting powder dissolved in buer A (Schreiber et al., 1989) and further homogenized for 1 min on ice (PowerGen 125, Fisher Scienti®c). Buers A and C both contained 1 mM DTT, 0.4 mg/ml Pefablock, 25 mg/ml Aprotinin, 10 mg/ml Pepstatin, and 10 mg/ml Leupeptin (Boehringer Mannheim) to inhibit proteases and in addition buer C contained 25% glycerol. Protein concentrations were standardized using the Bradford assay (BioRad) and equal loading (30 mg/lane) was con®rmed by Coomassie blue staining. All gels were run at the same time, using the same antibody solutions and exposed to the same ®lm. The ®lm was cut to maintain the order of labeling in Figure 3 . Western blot analysis was performed using a polyclonal rabbit-anti-mouse antibody directed against p27 at 1 : 500 (C-19, Santa Cruz Inc.) or p21 at 1 : 1000 (PharMingen), respectively.
Immunohistochemistry
Sections of skin, papillomas and carcinomas were removed and ®xed in 10% neutral buered formalin for 4 ± 6 h, embedded in paran, processed and cut to 3 ± 4 mm. After high temperature antigen retrieval in 10 mM citrate buer, pH 6.0, sections were stained with a mouse monoclonal antibody to p27 (Neomarkers, Fremont, CA, USA) for 1 h. Serial sections were stained with a Ki67 antibody (Novocastra Laboratories Ltd., Newcastle upon Tyne, UK) for 1 h, followed by a standard avidin-biotin peroxidase complex (ABC) technique with biotinylated goat anti-rabbit antibody (Vector Labs Inc., Burlingame, CA, USA) followed by streptavidin ABC (DAKO Corp., Carpinteria, CA). The slides were developed in DAB/NiCl, then counterstained with methyl green. Controls included: no primary antibody and/or normal rabbit serum, and tissues from p27 null mice.
Statistics
The bi-weekly papilloma counts were compared between the null, heterozygous and wild type groups using a Poisson regression model with robust Huber/White variance estimation to adjust for the correlation between successive observations on individual mice (Strata Statistical Software v5.0, Strata Corp, College Station, TX, USA). The regression model included terms for time of observation and for genotype group. For the p27 data, counts recorded after week 21 were excluded from the group comparisons because mice began to die o selectively due to skin carcinoma, heavy papilloma load, or other tumor development after that point. For the p21 data, counts recorded after week 19 were excluded for the same reason. The time until development of a carcinoma requiring euthanasia was graphically summarized with cumulative incidence estimators (Kalb¯eish et al., 1980) . Tests for increased risk of carcinoma for the null or heterozygous groups versus the wild-type group were conducted using the logrank test (Kalb¯eish et al., 1980) . Animals that died or were sacri®ced for causes other than skin carcinoma were considered censored observations in the logrank analyses. They were included in the analysis of overall mortality of p27 mice. Tumor grade was scored by two individuals without knowledge of sample genotype and Fisher's exact test was used to compare the number of high grade tumors in p217/7 and wild-type mice.
Note added in proof A recent study, using a similar two stage chemical induction protocol, has shown that p21 null mice on a 129/SvEv genetic background developed a greater number of papillomas relative to control littermates (Weinberg et al., 1999 Cancer Res., 59, 2050 ± 2054 . Our study, which did not show a signi®cant increase in papillomas from p21 null mice, was performed on a mixed Black Swiss/129/NIH genetic background. There are two possible explanations for the dierent results. Our study used four times the amount of DMBA and 2.5 times the dose of TPA which could overcome any phenotype due to p21 de®ciency. Secondly, the genetic backgrounds of the mice diered between the two studies and this could in¯uence the eects of p21 on papilloma induction. Our background included the NIH strain which is highly susceptible to papilloma induction ( Figure 6 ). Both studies show that p21 de®ciency did not result in an increase in malignant progression, however we observed a signi®cant eect of p21 on malignant tumor grade.
